Clinical Outcomes of Placenta Previa - an Individualized Scoring System

Launched by ASSIUT UNIVERSITY · Sep 5, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on developing a new way to predict how placenta previa—a condition where the placenta covers the cervix—will affect pregnant women. The researchers aim to create a special model using information about the patients' health and the characteristics of their condition. This model will help doctors make personalized care plans for each woman, including decisions about when to deliver the baby, how to deliver it, and how to manage any potential complications, like heavy bleeding before or after delivery.

To participate in the trial, women need to be at least 18 years old and diagnosed with placenta previa during a routine ultrasound between 18 to 21 weeks of pregnancy. They must also agree to allow their anonymous information to be used for research. However, women with certain previous surgeries or medical conditions that could complicate their pregnancy may not be eligible. If you join the study, you can expect close monitoring and tailored care to ensure the best outcomes for both you and your baby.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnant women diagnosed with placenta previa at time of routine second trimester ultrasound (18 to 21 weeks of gestation).
• • Aged 18 years old or above. Diagnosed with PP, followed-up antenatally and delivered within the same center.
• • Authorization to use anonymous patient data for research purposes
• Exclusion Criteria:
• • Inadequate documentation. Non-compliance to antenatal care. Previous 1 or more Cesarean deliveries. Previous uterine surgeries that approach the uterine cavity (myomectomy). Known untreated uterine septum. Maternal chronic medical condition that is associated with higher risk of placental insufficiency (including chronic hypertension, pregestational diabetes, chronic renal disease, autoimmune disease).
• • Fetal major congenital anomalies